4.5 Article

Effectiveness of Extracorporeal Shockwave Therapy on Controlling Spasticity in Cerebral Palsy Patients: A Meta-Analysis of Timing of Outcome Measurement

Journal

CHILDREN-BASEL
Volume 10, Issue 2, Pages -

Publisher

MDPI
DOI: 10.3390/children10020332

Keywords

cerebral palsy; extracorporeal shockwave therapy; range of motion; plantar surface area; modified ashworth scale; meta-analysis

Categories

Ask authors/readers for more resources

Extracorporeal shockwave therapy (ESWT) has shown effectiveness in reducing spasticity in patients with cerebral palsy (CP), although its duration of effect is limited. A meta-analysis of three studies found that ESWT significantly reduced spasticity, as measured by the modified Ashworth scale, compared to a control group, but the effect only lasted for 1 month. However, significant improvements in passive ankle range of motion and plantar surface area were observed for up to 3 months. ESWT appears to be a useful and effective therapeutic option for managing spasticity in patients with CP.
Extracorporeal shockwave therapy (ESWT) has been suggested as an alternative treatment for reducing spasticity in patients with cerebral palsy (CP). However, the duration of its effect was rarely known. A meta-analysis was performed to investigate the effectiveness of ESWT at controlling spasticity in patients with CP according to the follow-up period. We included studies in which ESWT was used to manage spasticity in patients with CP, and the effect was compared with that in a control group. Finally, three studies were included. In the meta-analysis, spasticity, measured using the modified Ashworth scale (MAS), was significantly reduced after ESWT compared with that in the control group; however, it was sustained for only 1 month. After ESWT, significant increases in passive ankle range of motion (ROM) and plantar surface area in the standing position were observed compared with those in the control group and sustained for up to 3 months. Although spasticity measured using MAS was significantly reduced for only 1 month, improvement in spasticity-associated symptoms, such as ankle ROM and plantar surface area contacting the ground, persisted for over 3 months. ESWT appears to be a useful and effective therapeutic option for managing spasticity in patients with CP.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available